Meanwhile, western blot analysis revealed that xenograft tumor treated by TMZ showed increased expression of TGF-β1/CTGF signal axis and higher expression of MDR phenotype (MDR1, MRP1, BCRP) and MGMT on day 35 as compared to the PBS Control group (Figure 7e). The gene discussed is CCN2; the disease is neoplasm.